Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADH1B | P00325 | 4/20 | 0.41 |
| ▸ | ADH1A | P07327 | 4/20 | 0.41 |
| ▸ | ADH1C | P00326 | 3/20 | 0.41 |
| ▸ | ADH7 | P40394 | 3/20 | 0.38 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.34 |
| ▸ | ADH4 | P08319 | 1/20 | 0.34 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.31 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10048338 | 0.79 | ADH1B (0.44) | ADH1BADH1AADH1CADH7EPHX1 | |
| SCHEMBL27667488 | 0.79 | ADH1B (0.44) | ADH1BADH1AADH1CADH7EPHX1 | |
| SCHEMBL8628353 | 0.72 | ADH1B (0.50) | ADH1BADH1AADH1CADH7EPHX1 | |
| SCHEMBL13950294 | 0.72 | ADH1B (0.50) | ADH1BADH1AADH1CADH7EPHX1 | |
| SCHEMBL269153 | 0.70 | — | — | |
| SCHEMBL8693116 | 0.68 | TSHR (0.46) | ADH1BADH1AADH1CADH7EPHX1 | |
| SCHEMBL28310278 | 0.68 | ADH1B (0.46) | ADH1BADH1AADH1CADH7EPHX1 | |
| SCHEMBL25604176 | 0.67 | ADH1B (0.50) | ADH1BADH1AADH1CADH7EPHX1 | |
| SCHEMBL8627522 | 0.66 | ADH1B (0.46) | ADH1BADH1AADH1CADH7EPHX1 | |
| SCHEMBL6050817 | 0.66 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4122926-A1 | TRIAZINE DERIVATIVE HAVING VIRUS PROPAGATION INHIBITORY EFFECT, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | Shionogi & Co., Ltd (JP) | 2023-01-25 | — | — | EP | disclosed |